Friess Associates’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-87,750
Closed -$7.31M 123
2018
Q1
$7.31M Buy
+87,750
New +$7.91M 0.6% 66
2013
Q3
Sell
-265,000
Closed -$5.83M 156
2013
Q2
$5.83M Buy
+265,000
New +$5.79M 0.46% 62

Other funds holding INCY

Friess Associates's INCY Position: Q2 2018 in Review

Friess Associates sold out of Incyte (INCY) in Q2 2018, closing a stake of 87,750 shares — an estimated $7.31M sold.

Friess Associates first reported a position in INCY in Q2 2013 and held it in 2 quarters. The position peaked at $7.31M in Q1 2018. 452 funds tracked by Wall St. Rank hold INCY as of Q2 2018.

  • Friess Associates reported no remaining Incyte position as of Q2 2018 after selling out during the quarter.
  • Friess Associates sold 87,750 Incyte shares in Q2 2018, an estimated $7.31M.
  • Friess Associates first reported a position in Incyte in Q2 2013 and held it in 2 quarters.
  • Friess Associates's Incyte position peaked at $7.31M in Q1 2018.
  • 452 funds tracked by Wall St. Rank held Incyte as of Q2 2018.

Based on Friess Associates's 13F filing for Q2 2018, filed 14 Aug 2018.